All News

Menstrual cups have been associated with improved financial and environmental impacts, along with being safe and effective for use in patients.

Sadia Haider, MD, MPH, talks about the latest guidelines from the Society of Family Planning regarding contraception for trans patients, RH testing during pregnancy, and Depo-Provera self-administration at the 2023 ACOG Annual Clinical and Scientific Meeting.

In a recent commentary, the NIH and FDA are urging leaders to increase research on drug-detection tools such as fentanyl test strips, along with removing barriers to access.

The Nella Single-Use Vaginal Speculum is now available for use in gynecologic exams.

Patients who exhibited unrestful sleep had significantly reduced health-related quality of life and significantly more depressive symptoms.

In a recent study, parental socioeconomic status and infant gestational age at birth both impacted neonatal brain structure.

Clinicians need to stay up-to-date with medication and access issues.

In a recent study, patient-reported outcomes were more effective for measuring aesthetic outcomes than expert panels or computerized software in patients with breast cancer.

More than 200 nursing organizations send letter to congress supporting the bill.

Technology may be used in ultrasounds, fetal heart rate interpretation, and prediction of adverse clinical outcomes.

In a recent article, the benefits in identifying and managing adnexal masses during pregnancy from ultrasound were discussed.

In a recent review, vaginal estrogen was effective for treating urinary symptoms in postmenopausal women.

Patients in the land- and water-based exercise intervention groups demonstrated greater improvements in fatigue when compared with controls.

In a recent study, providers were more likely to recommend combined hormone replacement therapy (HRT) than estrogen-only HRT in patients with severe endometriosis because of recurrence risks from estrogen-only HRT.

Patients are the biggest offenders, but many also encounter racism from colleagues and supervisors.

In a recent study, nulliparous women with postpartum urinary incontinence recovered without intervention.

In a recent study, the risks of neonatal low birth weight and perinatal depressive symptoms were greater in women who often or always felt unsafe in their neighborhood.

Study finds providing medications for free lowered median health care spending by $1641 annually.

In a recent study, states with more comprehensive health insurance had improved rates of postpartum attendance visits, but data on long-term health outcomes was insufficient.

The North American Menopause Society Advisory Panel has announced the release of their 2023 position statement on nonhormonal therapy for menopause.

A pair of studies presented at EULAR 2023 offer perspective on the potential for postpartum depression as well as symptoms of depression and anxiety during pregnancy among women with rheumatic disease.

Daré Bioscience has announced positive results from a phase 2b trial analyzing the safety and efficacy of sildenafil cream, 3.6% in women with female sexual arousal disorder.

In a recent study, transvaginal ultrasound examination was effective at predicting placenta accreta spectrum in patients with a history of cesarean delivery.

Survey examines yearly evolution of patient, doctor feelings on access to care.

Reductions in symptom incidence and severity from uterine fibroids and endometriosis have been observed in patients receiving relugolix combination therapy.

Adverse events were significantly more frequently reported by pregnant patients when compared with non-pregnant patients. However, no differences were observed when comparing pregnant patients with autoimmune disease and healthy controls.

In a recent study, increased samples of messenger RNA, microRNA, and long noncoding RNA were found in patients with preeclampsia compared to normotensive patients.

In a recent study, rates of stillbirth were higher in pregnancies with increased maternal body mass index.

A study comparing the symptoms of female sexual arousal disorder in premenopausal and postmenopausal women has been published by Daré Bioscience.

Expanding peripartum prophylaxis could be more cost-effective, but would likely lead to significant over-treatment.